Due to holidays, SignalChem's last days of shipping will be as follow: International Dec 14, 2018, US Dec 19, 2018. The shipments will resume on International Jan 4, 2019, and US Jan 7, 2019, as usual.
Anti-AXL(A34-63R)

Anti-AXL(A34-63R)

  • $270.00


FOR BULK ORDER REQUESTS PLEASE CONTACT US

Description :Rabbit Polyclonal Antibody

Species :

Tag :

Expression System:

Sequence :

Specificity :Recognizes the AXL protein

Cited Applications :WB, ELISA

Cross Reactivity :Human

Host / Isotype / Clone# :Rabbit, IgG

Immunogen :Peptide at the N-terminal residues of human AXL protein.

Purification :Affinity chromatography

Stability :Store at 4oC (add 0.1% NaN3) for several months, and at -20oC for longer periods. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.

Scientific Background :AXL is a member of the receptor tyrosine kinase family which has oncogenic potential and is implicated in human myeloid leukemia (1). AXL is a member of a complex signaling network that is involved in the control of cell proliferation and differentiation. Overexpression of AXL cDNA in NIH 3T3 cells induces neoplastic transformation of these cells with the concomitant appearance of a 140kDa AXL tyrosine-phosphorylated protein (2). Expression of AXL cDNA in the baculovirus system results in the expression of the appropriate recombinant protein that is recognized by anti-phosphotyrosine antibodies, confirming that the AXL protein is tyrosine phosphorylated.

References  :
1. O'Bryan, J.P. et al: Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol. 1991 Oct;11(10):5016-31.

2. Janssen, J.W. et al:, A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene. 1991 Nov;6(11):2113-20.

Product Sheets (By Lot #) :

Z2014-29.pdf

Research Areas :Angiogenesis, Cancer, Receptor Tyrosine Kinases, Cancer, Angiogenesis, Receptor Tyrosine Kinases